US 8143277
Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8143277 (Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P11/16